Overview
Labcorp Holdings Inc., based in the United States, is a leading global life sciences company primarily engaged in providing comprehensive clinical laboratory and end-to-end drug development services. Operating extensively in the healthcare sector, Labcorp capitalizes on its expertise in medical diagnostics and its robust capabilities in patient testing, biomarker detection, and pharmaceutical research. Key projects frequently involve collaboration with biotechnology and pharmaceutical clients to support clinical trials and drug discovery efforts, reflecting its pivotal role in advancing medical science and tailored healthcare solutions. Labcorp’s offerings further extend to technology applications in precision medicine, making significant contributions to personalized medical approaches and enhancing patient outcomes.
AI+ Ask Fintel’s AI assistant about Labcorp Holdings Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Labcorp Holdings Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 97.50 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-28 |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.10 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | 0.00 |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 0.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Labcorp Holdings Inc. is MX$6,077.14. The forecasts range from a low of MX$5,217.90 to a high of MX$6,676.37. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
| Record Date | Projection Date | High | Low | Median | Average |
|---|---|---|---|---|---|
| 2023-04-01 | 2024-04-01 | 6,676.37 | 5,217.90 | 6,080.26 | 6,077.14 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Labcorp Holdings Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-12-13 | B of A Securities | Buy | Buy | Maintains |
| 2025-02-03 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-28 | UBS | Buy | Buy | Maintains |
| 2025-01-07 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2024-12-17 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-07-09 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-08 | Baird | Outperform | Outperform | Maintains |
| 2024-05-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-04-26 | Truist Securities | Buy | Buy | Maintains |
| 2024-04-26 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-26 | Baird | Outperform | Outperform | Maintains |
| 2024-03-25 | Argus Research | Hold | Buy | Upgrade |
| 2024-02-26 | Leerink Partners | Outperform | Initiate | |
| 2024-02-09 | Evercore ISI Group | In-Line | Initiate | |
| 2024-01-03 | Barclays | Equal-Weight | Initiate | |
| 2023-11-17 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-10-31 | Mizuho | Buy | Buy | Maintains |
| 2023-09-21 | B of A Securities | Buy | Buy | Maintains |
| 2023-09-18 | Baird | Outperform | Outperform | Maintains |
| 2023-09-15 | Truist Securities | Buy | Buy | Reiterate |
| 2023-09-15 | Mizuho | Buy | Buy | Reiterate |
| 2023-09-06 | HSBC | Hold | Initiate | |
| 2023-08-14 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-03 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-02 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-07-31 | Baird | Outperform | Outperform | Maintains |
| 2023-07-28 | Truist Securities | Buy | Buy | Maintains |
| 2023-06-05 | Credit Suisse | Outperform | Outperform | Reiterate |
| 2023-05-16 | Mizuho | Buy | Buy | Maintains |
| 2023-05-10 | Morgan Stanley | Overweight | Maintains | |
| 2023-05-01 | Truist Securities | Buy | Maintains | |
| 2023-03-13 | Credit Suisse | Outperform | Maintains | |
| 2023-02-21 | Credit Suisse | Outperform | Maintains | |
| 2023-02-21 | Wells Fargo | Overweight | Maintains | |
| 2023-02-17 | Citigroup | Neutral | Maintains | |
| 2023-02-17 | Truist Securities | Buy | Maintains | |
| 2023-02-17 | Baird | Outperform | Maintains | |
| 2023-02-17 | Mizuho | Buy | Maintains | |
| 2023-01-11 | Baird | Outperform | Maintains | |
| 2023-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-12-12 | Citigroup | Buy | Neutral | Downgrade |
| 2022-11-23 | Credit Suisse | Outperform | Maintains | |
| 2022-11-03 | Mizuho | Buy | Maintains | |
| 2022-10-31 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-28 | Truist Securities | Buy | Maintains | |
| 2022-08-01 | Credit Suisse | Outperform | Maintains | |
| 2022-07-29 | Mizuho | Buy | Maintains | |
| 2022-05-25 | Morgan Stanley | Overweight | Maintains | |
| 2022-05-03 | Deutsche Bank | Hold | Maintains | |
| 2022-05-02 | Credit Suisse | Outperform | Maintains | |
| 2022-04-25 | Wells Fargo | Overweight | Maintains | |
| 2022-02-14 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-11 | Credit Suisse | Outperform | Maintains | |
| 2022-01-28 | Deutsche Bank | Buy | Hold | Downgrade |
| 2021-12-20 | Mizuho | Buy | Maintains | |
| 2021-12-17 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-14 | Wells Fargo | Overweight | Maintains | |
| 2021-11-01 | Credit Suisse | Outperform | Maintains | |
| 2021-10-29 | Morgan Stanley | Overweight | Maintains | |
| 2021-08-31 | Morgan Stanley | Overweight | Maintains | |
| 2021-08-20 | Credit Suisse | Outperform | Maintains | |
| 2021-08-19 | Mizuho | Buy | Maintains | |
| 2021-07-30 | Deutsche Bank | Buy | Maintains | |
| 2021-07-30 | Mizuho | Buy | Maintains | |
| 2021-05-20 | Argus Research | Buy | Maintains | |
| 2021-05-12 | Mizuho | Buy | Maintains | |
| 2021-05-03 | Jefferies | Buy | Maintains | |
| 2021-04-14 | Truist Securities | Above Average | Buy | Maintains |
| 2021-02-12 | Mizuho | Buy | Maintains | |
| 2021-02-12 | Citigroup | Buy | Maintains | |
| 2021-01-29 | Citigroup | Buy | Maintains | |
| 2021-01-14 | Mizuho | Buy | Maintains | |
| 2021-01-11 | Argus Research | Hold | Buy | Upgrade |
| 2020-10-28 | Wells Fargo | Overweight | Maintains | |
| 2020-07-29 | B of A Securities | Buy | Maintains | |
| 2020-07-14 | B of A Securities | Neutral | Buy | Upgrade |
| 2020-07-13 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2020-06-08 | Baird | Outperform | Maintains | |
| 2020-06-02 | Deutsche Bank | Buy | Reiterate | |
| 2020-05-21 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-05-20 | Morgan Stanley | Overweight | Maintains | |
| 2020-05-15 | Mizuho | Neutral | Buy | Upgrade |
| 2020-05-05 | UBS | Buy | Maintains | |
| 2020-04-30 | B of A Securities | Neutral | Reiterate | |
| 2020-04-30 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-27 | Citigroup | Neutral | Buy | Upgrade |
| 2020-04-23 | Barclays | Overweight | Maintains | |
| 2020-04-16 | Mizuho | Neutral | Maintains | |
| 2020-04-13 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-08 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-02 | JP Morgan | Overweight | Maintains | |
| 2020-03-30 | KeyBanc | Overweight | Maintains | |
| 2020-03-30 | Wells Fargo | Overweight | Maintains | |
| 2020-03-26 | Barclays | Overweight | Maintains | |
| 2020-02-25 | Mizuho | Neutral | Maintains | |
| 2020-02-18 | Morgan Stanley | Overweight | Maintains | |
| 2020-02-14 | Citigroup | Neutral | Maintains | |
| 2020-01-08 | Wells Fargo | Overweight | Initiate | |
| 2019-10-21 | UBS | Buy | Maintains | |
| 2019-08-23 | Morgan Stanley | Overweight | Maintains | |
| 2019-08-08 | KeyBanc | Overweight | Maintains | |
| 2019-07-26 | Morgan Stanley | Overweight | Maintains | |
| 2019-07-16 | Bank of America | Underperform | Neutral | Upgrade |
| 2019-06-21 | Deutsche Bank | Hold | Buy | Upgrade |
| 2019-05-02 | Canaccord Genuity | Hold | Hold | Maintains |
| 2019-05-01 | UBS | Buy | Buy | Maintains |
| 2019-05-01 | Citigroup | Neutral | Neutral | Maintains |
| 2019-04-02 | Jefferies | Hold | Buy | Upgrade |
| 2019-03-18 | Barclays | Overweight | Overweight | Maintains |
| 2019-02-27 | Credit Suisse | Outperform | Outperform | Maintains |
| 2019-01-17 | UBS | Buy | Initiate | |
| 2019-01-03 | Bank of America | Neutral | Underperform | Downgrade |
| 2018-12-06 | KeyBanc | Overweight | Overweight | Maintains |
| 2018-12-03 | Barclays | Overweight | Overweight | Maintains |
| 2018-12-03 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-12-03 | Citigroup | Neutral | Neutral | Maintains |
| 2018-12-03 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-11-30 | Goldman Sachs | Conviction Buy | Buy | Downgrade |
| 2018-10-30 | Argus | Buy | Hold | Downgrade |
| 2018-10-25 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2018-10-25 | Baird | Outperform | Outperform | Maintains |
| 2018-10-25 | Citigroup | Neutral | Neutral | Maintains |
| 2018-09-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-09-04 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-08-20 | Deutsche Bank | Hold | Hold | Maintains |
| 2018-06-27 | Deutsche Bank | Buy | Hold | Downgrade |
| 2018-06-07 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2018-03-23 | Argus | Buy | Initiate | |
| 2018-03-08 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-03-01 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-02-28 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-02-28 | Canaccord Genuity | Buy | Buy | Maintains |
| 2018-02-26 | Barclays | Overweight | Overweight | Maintains |
| 2018-02-09 | Baird | Neutral | Neutral | Maintains |
| 2018-02-09 | Citigroup | Neutral | Neutral | Maintains |
| 2018-01-05 | Evercore ISI Group | Outperform | Initiate | |
| 2017-10-26 | Barclays | Overweight | Maintains | |
| 2017-10-26 | Deutsche Bank | Buy | Maintains | |
| 2017-09-11 | Canaccord Genuity | Buy | Maintains | |
| 2017-08-10 | Morgan Stanley | Overweight | Maintains | |
| 2017-07-27 | Barclays | Overweight | Maintains | |
| 2017-06-27 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2017-02-06 | Baird | Outperform | Neutral | Downgrade |
| 2017-01-18 | Deutsche Bank | Buy | Initiate | |
| 2016-09-09 | Citigroup | Neutral | Initiate | |
| 2016-08-16 | KeyBanc | Overweight | Maintains | |
| 2016-07-28 | UBS | Neutral | Maintains | |
| 2016-04-26 | Barclays | Overweight | Maintains | |
| 2016-04-26 | Jefferies | Hold | Maintains | |
| 2016-04-26 | Canaccord Genuity | Buy | Maintains | |
| 2016-04-26 | UBS | Neutral | Maintains | |
| 2016-03-15 | Credit Suisse | Outperform | Initiate | |
| 2016-02-23 | Deutsche Bank | Hold | Maintains | |
| 2016-02-16 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2015-12-08 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2015-06-16 | KeyBanc | Overweight | Initiate | |
| 2015-04-28 | JP Morgan | Overweight | Maintains | |
| 2015-04-28 | Jefferies | Hold | Maintains | |
| 2015-03-27 | JMP Securities | Market Outperform | Initiate | |
| 2015-03-24 | Maxim Group | Buy | Maintains | |
| 2015-03-03 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2015-03-02 | Barclays | Overweight | Initiate | |
| 2015-02-23 | Morgan Stanley | Underweight | Overweight | Upgrade |
| 2015-02-23 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2015-02-23 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2015-02-02 | UBS | Buy | Neutral | Downgrade |
| 2015-01-20 | Evercore ISI Group | Hold | Buy | Upgrade |
| 2015-01-12 | Baird | Neutral | Outperform | Upgrade |
| 2015-01-08 | JP Morgan | Neutral | Overweight | Upgrade |
| 2015-01-05 | Citigroup | Buy | Maintains | |
| 2015-01-02 | Raymond James | Underperform | Outperform | Upgrade |
| 2014-11-13 | Deutsche Bank | Buy | Hold | Downgrade |
| 2014-11-03 | Deutsche Bank | Buy | Maintains | |
| 2014-10-29 | Citigroup | Neutral | Maintains | |
| 2014-10-29 | JP Morgan | Neutral | Maintains | |
| 2014-10-29 | FBR Capital | Market Perform | Maintains | |
| 2014-10-28 | FBR Capital | Market Perform | Maintains | |
| 2014-08-13 | UBS | Buy | Maintains | |
| 2014-07-17 | William Blair | Market Perform | Outperform | Upgrade |
| 2014-05-09 | Cantor Fitzgerald | Buy | Maintains | |
| 2014-03-27 | Citigroup | Neutral | Maintains | |
| 2014-02-10 | Deutsche Bank | Hold | Buy | Upgrade |
| 2013-12-18 | JMP Securities | Market Perform | Initiate | |
| 2013-12-11 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2013-12-11 | Deutsche Bank | Hold | Maintains | |
| 2013-12-11 | Citigroup | Neutral | Maintains | |
| 2013-11-19 | ISI Group | Neutral | Initiate | |
| 2013-09-13 | Cantor Fitzgerald | Buy | Initiate | |
| 2013-09-12 | Cantor Fitzgerald | Buy | Initiate | |
| 2013-08-28 | Craig-Hallum | Buy | Initiate | |
| 2013-07-12 | Baird | Neutral | Initiate | |
| 2013-04-19 | Deutsche Bank | Hold | Maintains | |
| 2013-04-11 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2013-02-11 | UBS | Neutral | Maintains | |
| 2013-01-28 | Oppenheimer | Perform | Initiate | |
| 2012-11-19 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2012-10-18 | Goldman Sachs | Neutral | Maintains | |
| 2012-10-18 | Canaccord Genuity | Buy | Maintains | |
| 2012-10-08 | Deutsche Bank | Hold | Maintains | |
| 2012-07-19 | Goldman Sachs | Neutral | Maintains | |
| 2012-07-17 | William Blair | Outperform | Market Perform | Downgrade |
| 2012-07-17 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2012-07-02 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2012-06-21 | Canaccord Genuity | Buy | Initiate | |
| 2012-05-31 | Deutsche Bank | Buy | Maintains | |
| 2012-03-02 | Jefferies | Hold | Maintains | |
| 2025-05-06 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-06-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-08-02 | Baird | Outperform | Outperform | Maintains |
| 2024-08-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-02 | UBS | Buy | Buy | Maintains |
| 2024-08-02 | Deutsche Bank | Hold | Hold | Maintains |
| 2024-08-02 | Truist Securities | Buy | Buy | Maintains |
| 2025-04-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-01 | Piper Sandler | Neutral | Initiate | |
| 2024-08-05 | B of A Securities | Buy | Buy | Maintains |
| 2025-04-02 | Redburn Atlantic | Buy | Initiate | |
| 2025-04-30 | Baird | Outperform | Outperform | Maintains |
| 2025-02-10 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-02-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-06 | Jefferies | Buy | Buy | Maintains |
| 2024-09-24 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-09-23 | Jefferies | Buy | Buy | Maintains |
| 2024-09-20 | Baird | Outperform | Outperform | Maintains |
| 2025-04-11 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-25 | UBS | Buy | Buy | Maintains |
| 2025-07-25 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-25 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-25 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-07-25 | Baird | Outperform | Outperform | Maintains |
| 2024-10-30 | HSBC | Hold | Buy | Upgrade |
| 2024-10-28 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-10-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-25 | Baird | Outperform | Outperform | Maintains |
| 2024-10-16 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-04 | Citigroup | Neutral | Buy | Upgrade |
| 2025-07-09 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-05-12 | Truist Securities | Buy | Buy | Maintains |
| 2025-04-30 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-18 | UBS | Buy | Buy | Maintains |
